Elevated Aurora B expression contributes to chemoresistance and poor prognosis in breast cancer.

In conclusion, elevated Aurora-B expression in breast cancer patients contributes to chemoresistance and predicts poor prognosis. PMID: 25755770 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/25755770?dopt=Abstract

Source: Clinical Breast Cancer - March 13, 2015 Category: Cancer & Oncology Authors: Zhang Y, Jiang C, Li H, Lv F, Li X, Qian X, Fu L, Xu B, Guo X Tags: Int J Clin Exp Pathol Source Type: research